Cargando…
Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett’s esophagus who have elevated genomic instability
Background: The surveillance of patients with nondysplastic Barrett’s esophagus (NDBE) has a high cost and is of limited effectiveness in preventing esophageal adenocarcinoma (EAC). Ablation for NDBE remains expensive and controversial. Biomarkers of genomic instability have shown promise in identif...
Autores principales: | Das, Ananya, Callenberg, Keith M., Styn, Mindi A., Jackson, Sara A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874803/ https://www.ncbi.nlm.nih.gov/pubmed/27227114 http://dx.doi.org/10.1055/s-0042-103415 |
Ejemplares similares
-
The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus
por: Eluri, Swathi, et al.
Publicado: (2015) -
Barrett Esophagus: When to Endoscope
por: Butt, Joshua, et al.
Publicado: (2014) -
Managing Barrett’s esophagus with radiofrequency ablation
por: Akiyama, Junichi, et al.
Publicado: (2013) -
The evolution of endoscopic therapy for Barrett’s
esophagus
por: Condon, Ashwinee, et al.
Publicado: (2021) -
The role of ablation in the treatment of dysplastic Barrett’s esophagus
por: Sullivan, Rebecca, et al.
Publicado: (2021)